OPKO Health, Inc. (OPK) vs Personalis, Inc. (PSNL)

OPKO Health, Inc. and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $1.2B — 1.4× the size. OPKO Health, Inc. grew revenue faster over the last twelve months: −11.5% against −13.3%. OPKO Health, Inc. has the higher net margin (−12.4% vs −153.8%) and the higher return on invested capital (−2.45% vs −317.5%). Across the 18 metrics below, OPKO Health, Inc. leads on 13 and Personalis, Inc. on 5.

Valuation

Metric OPK PSNL Diagnostics & Research median
P/E n/m n/m 35.56
P/S 1.97 23.68 4.37
P/B 0.98 7.02 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA 28.61 n/m 24.35
EV/Sales 2.04 20.89 5.51
Earnings yield (5.88%) (6.96%) (1.89%)
Free cash flow yield (12.44%) (6.11%) (0.15%)

Profitability

Metric OPK PSNL Diagnostics & Research median
Gross margin 40.77% 12.69% 50.89%
Operating margin (8.21%) (164.07%) (8.57%)
Net margin (12.40%) (153.84%) (6.37%)
Free cash flow margin (22.75%) (144.76%) 0.00%
Return on equity (5.88%) (50.32%) (2.92%)
Return on assets (3.83%) (37.55%) (6.71%)
Return on invested capital (2.45%) (317.48%) 0.00%

Growth

Metric OPK PSNL Diagnostics & Research median
Revenue growth (TTM) (11.47%) (13.26%) 7.69%
EPS growth (last fiscal year) (275.00%) 33.58% 25.92%
Revenue growth, 5-year CAGR (15.82%) (2.40%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OPK PSNL Diagnostics & Research median
Debt to equity 0.29 0.00 0.11
Current ratio 3.35 5.28 2.02
Net debt to EBITDA 1.33 2.93 0.70

Dividend

Metric OPK PSNL Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric OPK PSNL Diagnostics & Research median
Market cap 1.20b 1.70b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack